Subscribe
Business

News Summary: Teva Pharma in SEC bribery inquiry

By The Associated Press
Published
Add Washington Examiner on Google

THE INQUIRY: Teva Pharmaceutical Industries Ltd. says the Securities and Exchange Commission is investigating possible bribery by Teva’s business in Latin America. Teva said Thursday that it received a subpoena from the SEC in July.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.